Cart
sales@molnova.com
6-Methylnicotinamide
CAS No. 6960-22-1
6-Methylnicotinamide( —— )
Catalog No. M35895 CAS No. 6960-22-1
6-Methylnicotinamide is a derivative of nicotinamide, an endogenous metabolite. 6-Methylnicotinamide is used to make co-crystals/salts.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | In Stock |
|
Biological Information
-
Product Name6-Methylnicotinamide
-
NoteResearch use only, not for human use.
-
Brief Description6-Methylnicotinamide is a derivative of nicotinamide, an endogenous metabolite. 6-Methylnicotinamide is used to make co-crystals/salts.
-
Description6-Methylnicotinamide, a derivate of nicotinamide, is an endogenous metabolite. A sudden increase of 6-methylnicotinamide in the acute stages of intracerebral hemorrhage (ICH) exacerbates neurological damages.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6960-22-1
-
Formula Weight136.15
-
Molecular FormulaC7H8N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (367.24 mM; Ultrasonic )H2O : 3.33 mg/mL (24.46 mM; Ultrasonic (<60°C))
-
SMILESCC1=NC=C(C=C1)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. En Hu, et al. Temporal metabolomic alteration in rat brains of experimental intracerebral hemorrhage. Brain Res Bull. 2021 May;170:234-245.?
molnova catalog
related products
-
trans-Vaccenic acid
trans-Vaccenic acid is a precursor for the synthesis of saturated fatty acid in the rumen and of conjugated linoleic acid at the tissue level.
-
Allolithocholic acid
Allolithocholic acid (allo-LCA) is found in the urine of infants with biliary atresia and is often excreted as sulfate-conjugated bile acids.Allolithocholic acid promotes intestinal and hepatic metabolism.
-
5'-Guanylic acid
5'-Guanylic acid is involved in several metabolic disorders, including AICA-ribosiduria pathway, ?adenosine deaminase deficiency,adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.
